Comments
Commented by Fabian Lorenz on May 5th, 2025 | 07:00 CEST
NEW PRICE TARGET: RENK, Novo Nordisk, and takeover candidate BioNxt Solutions
Analysts are raising their price target for RENK shares significantly. However, they appear to be trailing the current share price. Things will likely get exciting at RENK on May 15, when fresh figures and, hopefully, a well-filled order book will be reported. BioNxt Solutions shares are currently of interest. Clinical trials are about to begin on the development of the leading product for the easier treatment of multiple sclerosis. The stock is cheap and seen as a hot takeover candidate - perhaps for Novo Nordisk? With simplified administration, the Danes could further accelerate sales of Ozempic and potentially reduce costs. The stock is working on a bottom, and analysts recommend it as a "Buy".
Read
Commented by Armin Schulz on May 2nd, 2025 | 07:00 CEST
Military, precious metals, AI technology: Why RENK Group, Golden Cariboo Resources, and Super Micro Computer are booming right now
2025 is shaping up to be a year of superlatives. The defense industry, gold market, and AI technology are all experiencing an unprecedented boom. While conflicts and arms races are causing demand for high-tech military solutions to skyrocket - with German defense giants recording double-digit growth rates - gold prices are soaring to record highs. Investors are fleeing to the safe haven of precious metals in the face of geopolitical turmoil and inflation. At the same time, AI is not only driving consumer goods but also revolutionizing security strategies and data infrastructure. We take a look at an exciting company from each of these sectors.
Read
Commented by Fabian Lorenz on May 1st, 2025 | 07:10 CEST
A bombshell at Nel ASA! Buying opportunity for Bayer and Defence Therapeutics shares?
A bombshell at Nel ASA. The hydrogen specialist has reported its first quarter results: revenue and order intake are down, while the Company is sliding deep into the red. Will new major shareholder Samsung bring about a turnaround? Defence Therapeutics is a hot rebound candidate with takeover speculation. The biotech company is consistently pushing ahead with the monetization of its technology and has found a strong partner. The decline in the share price in recent months offers opportunities. A lot of negative news is certainly already priced into Bayer's share price, but is that enough to buy the stock? Yes, according to analysts.
Read
Commented by Armin Schulz on May 1st, 2025 | 07:05 CEST
AI race in a billion-dollar market: How are Evotec, NetraMark Holdings, and Novo Nordisk doing in the race?
The pharmaceutical industry is undergoing a seismic change! Algorithms are replacing microscopes, and data pools are becoming the new pipeline for therapeutic breakthroughs. As billions are poured into artificial intelligence (AI), the battle is raging to crack the code for the next drug revolution – and to avoid drowning in a sea of data. Innovators like NetraMark are using machine learning to demystify clinical trials, while giants like Novo Nordisk are reinventing diabetes treatments with digital twins. Evotec is using AI-driven approaches to drug discovery. Who will succeed in bridging the gap between hype and healing?
Read
Commented by Nico Popp on May 1st, 2025 | 07:00 CEST
Raw materials for the future: What Power Metallic Mines, Barrick Gold, and Albemarle offer investors
Whether for the energy transition, digitalization, or the infrastructure of tomorrow, the world's hunger for raw materials is growing. Power Metallic Mines, Barrick Gold, and Albemarle are prime examples of tomorrow's raw material suppliers – from classic exploration to specialty metals for the green transformation. The three business models are different, but where do the most significant opportunities lie for investors? We provide new answers!
Read
Commented by Fabian Lorenz on April 30th, 2025 | 07:15 CEST
Buy BioNTech after the crash? Valneva with vaccine problems! Vidac Pharma shares show potential!
BioNTech shares crashed by around 10% on Friday. So far, they have not been able to recover. What caused the setback? Should investors seize the opportunity? Analysts believe the German biotech heavyweight is on track. The same applies to Vidac Pharma. The news flow is extremely positive, but the stock is not making any headway. Analysts believe that Vidac shares could multiply in value. If the biotech company continues to be successful, a takeover could follow. And what is going on at Valneva? The stock is on a rollercoaster ride. Could a vaccine become a problem?
Read
Commented by André Will-Laudien on April 30th, 2025 | 07:10 CEST
Here we go! Plug Power turns, rollout at dynaCERT, opportunities with Mutares, VW, and BYD?
Some say the volatility is unbearable, while traders shout: opportunities everywhere. The stock market is currently relentless. Those positioned poorly can quickly see double-digit losses, but on the upside, profits are once again within reach. The former high-tech favorites are taking off again. After a spectacular sell-off at Plug Power in April, there have been strong buybacks in recent days. dynaCERT is also going full steam ahead in sales. Mutares recently delivered rather disappointing figures, and BYD could become the world's most successful automotive company in 2025. We take a closer look.
Read
Commented by Armin Schulz on April 30th, 2025 | 07:05 CEST
The new gold rush: Barrick Gold, Globex Mining, and Rio Tinto are forging the supply chains of tomorrow
Global markets are trembling: trade wars are tearing supply chains apart, raw materials are becoming weapons, and gold is shining as the savior in times of crisis. With a record high of over USD 3,500 per ounce, the precious metal is taking centre stage - driven by inflation, geopolitical shock waves, and greedy central banks. Yet, in the background, a new power dynamic is taking shape: companies that are not only developing deposits but also forging the future of resource security. This is where it will be decided who pulls the strings in the chaos of trade blockades – and who becomes a pawn. Three players are suddenly in the spotlight: Barrick Gold, Globex Mining, and Rio Tinto.
Read
Commented by Nico Popp on April 30th, 2025 | 07:00 CEST
The future of digital content: MiMedia, Dropbox, and Amazon in the race for data sovereignty
Cloud services are simple and incredibly useful. Whether it is photos from past vacations, data from a long-term project from 2020, or the baking recipe Grandma sent us years ago via WhatsApp - all this information is now just a few swipes away. However, the more personal data we store online, the greater the risk. More and more customers are focusing on security. We look at the business models of cloud service providers MiMedia, Dropbox, and Amazon.
Read
Commented by Stefan Feulner on April 29th, 2025 | 07:15 CEST
Coinbase, Defence Therapeutics, Palantir – Forward-looking decisions
The current trading week promises to be super exciting. In addition to possible surprise posts from Donald Trump on his Truth Social platform regarding punitive tariffs, the highlight of the reporting season is coming up. Around 800 companies will provide insights into their annual reports over the next few days, including heavyweights such as Coca-Cola and Mastercard, as well as tech giants Microsoft, Meta Platforms, and Qualcomm.
Read